
ICON Public Company Investor Relations Material
Latest events

Q2 2025
ICON Public Company
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ICON Public Limited Company
Access all reports
ICON Public Limited Company is a global provider of clinical research and development services to the pharmaceutical, biotechnology, and medical device industries. The company offers a broad range of outsourced services, including clinical trial management, data analytics, regulatory support, and laboratory services. ICON works with clients to facilitate the development and approval of new medical treatments and therapies, supporting clinical trials from early-phase research through to post-market studies. The company's expertise spans multiple therapeutic areas and geographies. The company is headquartered in Dublin, Ireland, and its shares are listed on the NASDAQ.
Key slides for ICON Public Limited Company


Q2 2025
ICON Public Limited Company


43rd Annual J.P. Morgan Healthcare Conference 2025
ICON Public Limited Company
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ICLR
Country
🇺🇸 United States